$4.6B Biovail Suit Attacks Shorting By Hedge Funds

Law360, New York (February 23, 2006, 12:00 AM EST) -- Canada’s largest pharmaceutical company, Biovail Corporation, has filed a $4.6 billion lawsuit against 22 institutional and individual investors, alleging that powerful hedge funds conspired with Wall Street analysts in a plot to drive down the company’s shares.

The complaint, filed this week in a New Jersey state court, names hedge funds SAC Capital Management LLC and Sigma Capital Management LLC, as well as research shop Gradient Analytics and Bank of America analyst David Maris, among others, claiming the Wall Street bigwigs participated in a “massive, illegal,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.